메뉴 건너뛰기




Volumn 99, Issue 11, 2014, Pages 4299-4306

No evidence of ectopic lipid accumulation in the pathophysiology of the acromegalic cardiomyopathy

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; LIPID;

EID: 84910020567     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-2242     Document Type: Article
Times cited : (43)

References (51)
  • 1
    • 1442326975 scopus 로고    scopus 로고
    • Systemic complications of acromegaly: Epidemiology, pathogenesis, and management
    • Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrine Rev. 2004; 25: 102-152.
    • (2004) Endocrine Rev. , vol.25 , pp. 102-152
    • Colao, A.1    Ferone, D.2    Marzullo, P.3    Lombardi, G.4
  • 3
    • 66749090434 scopus 로고    scopus 로고
    • Free fatty acids inhibit growth hormone/signal transducer and activator of transcription-5 signaling in human muscle: A potential feedback mechanism
    • Moller N, Gormsen LC, Schmitz O, Lund S, Jorgensen JO, Jessen N. Free fatty acids inhibit growth hormone/signal transducer and activator of transcription-5 signaling in human muscle: a potential feedback mechanism. J Clin Endocrinol Metab. 2009; 94: 2204-2207.
    • (2009) J Clin Endocrinol Metab. , vol.94 , pp. 2204-2207
    • Moller, N.1    Gormsen, L.C.2    Schmitz, O.3    Lund, S.4    Jorgensen, J.O.5    Jessen, N.6
  • 4
    • 65249171425 scopus 로고    scopus 로고
    • Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects
    • Moller N, Jorgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev. 2009; 30: 152-177.
    • (2009) Endocr Rev. , vol.30 , pp. 152-177
    • Moller, N.1    Jorgensen, J.O.2
  • 5
    • 0024508821 scopus 로고
    • Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man
    • Moller N, Butler PC, Antsiferov MA, Alberti KG. Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man. Diabetologia. 1989; 32: 105-110.
    • (1989) Diabetologia. , vol.32 , pp. 105-110
    • Moller, N.1    Butler, P.C.2    Antsiferov, M.A.3    Alberti, K.G.4
  • 7
    • 45149127238 scopus 로고    scopus 로고
    • Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor i excess due to acromegaly
    • Freda PU, Shen W, Heymsfield SB, et al. Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly. J Clin Endocrinol Metab. 2008; 93: 2334-2343.
    • (2008) J Clin Endocrinol Metab. , vol.93 , pp. 2334-2343
    • Freda, P.U.1    Shen, W.2    Heymsfield, S.B.3
  • 10
    • 0038509036 scopus 로고    scopus 로고
    • Lipotoxicity: When tissues overeat
    • Schaffer JE. Lipotoxicity: when tissues overeat. Curr Opin Lipidol. 2003; 14: 281-287.
    • (2003) Curr Opin Lipidol. , vol.14 , pp. 281-287
    • Schaffer, J.E.1
  • 11
    • 58849088969 scopus 로고    scopus 로고
    • Ectopic lipids and organ function
    • Szendroedi J, Roden M. Ectopic lipids and organ function. Curr Opin Lipidol. 2009; 20: 50-56.
    • (2009) Curr Opin Lipidol. , vol.20 , pp. 50-56
    • Szendroedi, J.1    Roden, M.2
  • 13
    • 58049093391 scopus 로고    scopus 로고
    • Reduced basal ATP synthetic flux of skeletal muscle in patients with previous acromegaly
    • Szendroedi J, Zwettler E, Schmid AI, et al. Reduced basal ATP synthetic flux of skeletal muscle in patients with previous acromegaly. PloS One. 2008; 3: e3958.
    • (2008) PloS One. , vol.3 , pp. e3958
    • Szendroedi, J.1    Zwettler, E.2    Schmid, A.I.3
  • 14
    • 49649106996 scopus 로고    scopus 로고
    • The GH-IGF-I axis and the cardiovascular system: Clinical implications
    • Colao A. The GH-IGF-I axis and the cardiovascular system: clinical implications. Clin Endocrinol (Oxf). 2008; 69: 347-358.
    • (2008) Clin Endocrinol (Oxf). , vol.69 , pp. 347-358
    • Colao, A.1
  • 16
    • 50949116173 scopus 로고    scopus 로고
    • Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function
    • Hammer S, Snel M, Lamb HJ, et al. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J Am Coll Cardiol. 2008; 52: 1006-1012.
    • (2008) J Am Coll Cardiol. , vol.52 , pp. 1006-1012
    • Hammer, S.1    Snel, M.2    Lamb, H.J.3
  • 17
    • 39049116617 scopus 로고    scopus 로고
    • Progressive caloric restriction induces dose-dependent changes in myocardial triglyceride content and diastolic function in healthy men
    • Hammer S, van der Meer RW, Lamb HJ, et al. Progressive caloric restriction induces dose-dependent changes in myocardial triglyceride content and diastolic function in healthy men. J Clin Endocrinol Metab. 2008; 93: 497-503.
    • (2008) J Clin Endocrinol Metab. , vol.93 , pp. 497-503
    • Hammer, S.1    Van Der Meer, R.W.2    Lamb, H.J.3
  • 18
    • 84860564387 scopus 로고    scopus 로고
    • Short-term hyperinsulinemia and hyperglycemia increase myocardial lipid content in normal subjects
    • Winhofer Y, Krssak M, Jankovic D, et al. Short-term hyperinsulinemia and hyperglycemia increase myocardial lipid content in normal subjects. Diabetes. 2012; 61: 1210-1216.
    • (2012) Diabetes. , vol.61 , pp. 1210-1216
    • Winhofer, Y.1    Krssak, M.2    Jankovic, D.3
  • 19
    • 84870663187 scopus 로고    scopus 로고
    • Effects of insulin therapy on myocardial lipid content and cardiac geometry in patients with type-2 diabetes mellitus
    • Jankovic D, Winhofer Y, Promintzer-Schifferl M, et al. Effects of insulin therapy on myocardial lipid content and cardiac geometry in patients with type-2 diabetes mellitus. PloS One. 2012; 7: e50077.
    • (2012) PloS One. , vol.7 , pp. e50077
    • Jankovic, D.1    Winhofer, Y.2    Promintzer-Schifferl, M.3
  • 20
    • 77952959623 scopus 로고    scopus 로고
    • Non-invasive assessment of hepatic fat accumulation in chronic hepatitis C by 1H magnetic resonance spectroscopy
    • Krssak M, Hofer H, Wrba F, et al. Non-invasive assessment of hepatic fat accumulation in chronic hepatitis C by 1H magnetic resonance spectroscopy. Eur J Radiol. 2010; 74: e60-e66.
    • (2010) Eur J Radiol. , vol.74 , pp. e60-e66
    • Krssak, M.1    Hofer, H.2    Wrba, F.3
  • 21
    • 55949119360 scopus 로고    scopus 로고
    • Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus
    • Rijzewijk LJ, van der Meer RW, Smit JW, et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol. 2008; 52: 1793-1799.
    • (2008) J Am Coll Cardiol. , vol.52 , pp. 1793-1799
    • Rijzewijk, L.J.1    Van Der Meer, R.W.2    Smit, J.W.3
  • 22
    • 34548677080 scopus 로고    scopus 로고
    • Metabolic imagingof myocardial triglyceride content: Reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers
    • van der Meer RW, Doornbos J, Kozerke S, et al. Metabolic imagingof myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers. Radiology. 2007; 245: 251-257.
    • (2007) Radiology. , vol.245 , pp. 251-257
    • Van Der Meer, R.W.1    Doornbos, J.2    Kozerke, S.3
  • 23
    • 79959688924 scopus 로고    scopus 로고
    • Insulin resistance is not associated with myocardial steatosis in women
    • Krssak M, Winhofer Y, Gobl C, et al. Insulin resistance is not associated with myocardial steatosis in women. Diabetologia. 2011; 54: 1871-1878.
    • (2011) Diabetologia. , vol.54 , pp. 1871-1878
    • Krssak, M.1    Winhofer, Y.2    Gobl, C.3
  • 24
    • 2442651854 scopus 로고    scopus 로고
    • 1H NMR relaxation times of skeletal muscle metabolites at 3 T
    • Krssak M, Mlynarik V, Meyerspeer M, Moser E, Roden M. 1H NMR relaxation times of skeletal muscle metabolites at 3 T. Magma. 2004; 16: 155-159.
    • (2004) Magma. , vol.16 , pp. 155-159
    • Krssak, M.1    Mlynarik, V.2    Meyerspeer, M.3    Moser, E.4    Roden, M.5
  • 25
    • 77953638871 scopus 로고    scopus 로고
    • Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: The Framingham Heart Study
    • Velagaleti RS, Gona P, Chuang ML, et al. Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study. Circ Cardiovasc Imaging. 2010; 3: 257-263.
    • (2010) Circ Cardiovasc Imaging. , vol.3 , pp. 257-263
    • Velagaleti, R.S.1    Gona, P.2    Chuang, M.L.3
  • 26
    • 0032947433 scopus 로고    scopus 로고
    • Determination of normal regional left ventricular function from cine-MR images using a semi-automated edge detection method
    • Waiter GD, McKiddie FI, Redpath TW, Semple SI, Trent RJ. Determination of normal regional left ventricular function from cine-MR images using a semi-automated edge detection method. Magn Reson Imaging. 1999; 17: 99-107.
    • (1999) Magn Reson Imaging. , vol.17 , pp. 99-107
    • Waiter, G.D.1    McKiddie, F.I.2    Redpath, T.W.3    Semple, S.I.4    Trent, R.J.5
  • 27
    • 0024723470 scopus 로고
    • Recommendations for quantitation of the left ventricle by two-dimensional echocardiography
    • American Society of Echocardiography Committee on Standards Subcommittee on Quantitation of Two-Dimensional Echocardiograms
    • Schiller NB, Shah PM, Crawford M, et al et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989; 2: 358-367.
    • (1989) J Am Soc Echocardiogr. , vol.2 , pp. 358-367
    • Schiller, N.B.1    Shah, P.M.2    Crawford, M.3
  • 28
    • 70449086246 scopus 로고    scopus 로고
    • Contribution of glucose tolerance and gender to cardiac adiposity
    • Iozzo P, Lautamaki R, Borra R, et al. Contribution of glucose tolerance and gender to cardiac adiposity. J Clin Endocrinol Metab. 2009; 94: 4472-4482.
    • (2009) J Clin Endocrinol Metab. , vol.94 , pp. 4472-4482
    • Iozzo, P.1    Lautamaki, R.2    Borra, R.3
  • 29
    • 0035195538 scopus 로고    scopus 로고
    • Insulin and C-peptide secretion and kinetics in humans: Direct and model-based measurements during OGTT
    • Tura A, Ludvik B, Nolan JJ, Pacini G, Thomaseth K. Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT. Am J Physiol Endocrinol Metab. 2001; 281: E966-E974.
    • (2001) Am J Physiol Endocrinol Metab. , vol.281 , pp. E966-E974
    • Tura, A.1    Ludvik, B.2    Nolan, J.J.3    Pacini, G.4    Thomaseth, K.5
  • 30
    • 0035089445 scopus 로고    scopus 로고
    • A model-based method for assessing insulin sensitivity from the oral glucose tolerance test
    • Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care. 2001; 24: 539-548.
    • (2001) Diabetes Care. , vol.24 , pp. 539-548
    • Mari, A.1    Pacini, G.2    Murphy, E.3    Ludvik, B.4    Nolan, J.J.5
  • 31
    • 0036788388 scopus 로고    scopus 로고
    • Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle
    • Anderwald C, Bernroider E, Krssak M, et al. Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle. Diabetes. 2002; 51: 3025-3032.
    • (2002) Diabetes. , vol.51 , pp. 3025-3032
    • Anderwald, C.1    Bernroider, E.2    Krssak, M.3
  • 32
    • 84910009178 scopus 로고    scopus 로고
    • 127 Early manifestations of diabetic cardiomyopathy assessed by cardiac magnetic resonance imaging and spectroscopy
    • Levelt E, Ntusi N, Mahmod M, et al. 127 Early manifestations of diabetic cardiomyopathy assessed by cardiac magnetic resonance imaging and spectroscopy. Heart. 2014; 100(suppl 3): A73-A74.
    • (2014) Heart. , vol.100 , pp. A73-A74
    • Levelt, E.1    Ntusi, N.2    Mahmod, M.3
  • 33
    • 61849172978 scopus 로고    scopus 로고
    • Effects of high-dose simvastatin therapy on glucose metabolism and ectopic lipid deposition in nonobese type 2 diabetic patients
    • Szendroedi J, Anderwald C, Krssak M, et al. Effects of high-dose simvastatin therapy on glucose metabolism and ectopic lipid deposition in nonobese type 2 diabetic patients. Diabetes Care. 2009; 32: 209-214.
    • (2009) Diabetes Care. , vol.32 , pp. 209-214
    • Szendroedi, J.1    Anderwald, C.2    Krssak, M.3
  • 34
    • 84883740858 scopus 로고    scopus 로고
    • Effects of pioglitazone versus glimepiride exposure on hepatocellular fat content in type 2 diabetes
    • Phielix E, Brehm A, Bernroider E, et al. Effects of pioglitazone versus glimepiride exposure on hepatocellular fat content in type 2 diabetes. Diabetes Obes Metab. 2013; 15: 915-922.
    • (2013) Diabetes Obes Metab. , vol.15 , pp. 915-922
    • Phielix, E.1    Brehm, A.2    Bernroider, E.3
  • 35
    • 9444262473 scopus 로고    scopus 로고
    • Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes
    • Krssak M, Brehm A, Bernroider E, et al. Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. Diabetes. 2004; 53: 3048-3056.
    • (2004) Diabetes. , vol.53 , pp. 3048-3056
    • Krssak, M.1    Brehm, A.2    Bernroider, E.3
  • 36
    • 70349916249 scopus 로고    scopus 로고
    • Peak growth hormonereleasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity
    • Bredella MA, Torriani M, Thomas BJ, et al. Peak growth hormonereleasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity. J Clin Endocrinol Metab. 2009; 94: 3995-4002.
    • (2009) J Clin Endocrinol Metab. , vol.94 , pp. 3995-4002
    • Bredella, M.A.1    Torriani, M.2    Thomas, B.J.3
  • 37
    • 84883688944 scopus 로고    scopus 로고
    • Effects of GH on body composition and cardiovascular risk markers in young men with abdominal obesity
    • Bredella MA, Gerweck AV, Lin E, et al. Effects of GH on body composition and cardiovascular risk markers in young men with abdominal obesity. J Clin Endocrinol Metab. 2013; 98: 3864-3872.
    • (2013) J Clin Endocrinol Metab. , vol.98 , pp. 3864-3872
    • Bredella, M.A.1    Gerweck, A.V.2    Lin, E.3
  • 38
    • 0026715813 scopus 로고
    • Basal-and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy
    • Moller N, Schmitz O, Joorgensen JO, et al. Basal-and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy. J Clin Endocrinol Metab. 1992; 74: 1012-1019.
    • (1992) J Clin Endocrinol Metab. , vol.74 , pp. 1012-1019
    • Moller, N.1    Schmitz, O.2    Joorgensen, J.O.3
  • 39
    • 63749093594 scopus 로고    scopus 로고
    • Alterations in body composition in acromegaly
    • Katznelson L. Alterations in body composition in acromegaly. Pituitary. 2009; 12: 136-142.
    • (2009) Pituitary. , vol.12 , pp. 136-142
    • Katznelson, L.1
  • 40
    • 76149125135 scopus 로고    scopus 로고
    • Growth hormone deficiency after treatment of acromegaly: A randomized, placebo-controlled study of growth hormone replacement
    • Miller KK, Wexler T, Fazeli P, et al. Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement. J Clin Endocrinol Metab. 2010; 95: 567-577.
    • (2010) J Clin Endocrinol Metab. , vol.95 , pp. 567-577
    • Miller, K.K.1    Wexler, T.2    Fazeli, P.3
  • 41
    • 70349326750 scopus 로고    scopus 로고
    • Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
    • Fabbrini E, Magkos F, Mohammed BS, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA. 2009; 106: 15430-15435.
    • (2009) Proc Natl Acad Sci USA. , vol.106 , pp. 15430-15435
    • Fabbrini, E.1    Magkos, F.2    Mohammed, B.S.3
  • 42
    • 49449092403 scopus 로고    scopus 로고
    • Identification and characterization of metabolically benign obesity in humans
    • Stefan N, Kantartzis K, Machann J, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008; 168: 1609-1616.
    • (2008) Arch Intern Med. , vol.168 , pp. 1609-1616
    • Stefan, N.1    Kantartzis, K.2    Machann, J.3
  • 43
    • 17044383342 scopus 로고    scopus 로고
    • Supraphysiological growth hormone: Less fat, more extracellular fluid but uncertain effects on muscles in healthy, active young adults
    • Ehrnborg C, Ellegard L, Bosaeus I, Bengtsson BA, Rosen T. Supraphysiological growth hormone: less fat, more extracellular fluid but uncertain effects on muscles in healthy, active young adults. Clin Endocrinol (Oxf). 2005; 62: 449-457.
    • (2005) Clin Endocrinol (Oxf). , vol.62 , pp. 449-457
    • Ehrnborg, C.1    Ellegard, L.2    Bosaeus, I.3    Bengtsson, B.A.4    Rosen, T.5
  • 44
    • 0029560772 scopus 로고
    • Body fluids, circadian blood pressure and plasma renin during growth hormone administration: A placebo-controlled study with two growth hormone doses in healthy adults
    • Moller J, Jorgensen JO, Frandsen E, Laursen T, Christiansen JS. Body fluids, circadian blood pressure and plasma renin during growth hormone administration: a placebo-controlled study with two growth hormone doses in healthy adults. Scand J Clin Lab Invest. 1995; 55: 663-669.
    • (1995) Scand J Clin Lab Invest. , vol.55 , pp. 663-669
    • Moller, J.1    Jorgensen, J.O.2    Frandsen, E.3    Laursen, T.4    Christiansen, J.S.5
  • 45
    • 0029887207 scopus 로고    scopus 로고
    • Noninvasive assessment of hepatic triglyceride content in humans with 13C nuclear magnetic resonance spectroscopy
    • Petersen KF, West AB, Reuben A, Rothman DL, Shulman GI. Noninvasive assessment of hepatic triglyceride content in humans with 13C nuclear magnetic resonance spectroscopy. Hepatology. 1996; 24: 114-117.
    • (1996) Hepatology. , vol.24 , pp. 114-117
    • Petersen, K.F.1    West, A.B.2    Reuben, A.3    Rothman, D.L.4    Shulman, G.I.5
  • 46
    • 0034037529 scopus 로고    scopus 로고
    • Impairedβ-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients
    • Kasayama S, Otsuki M, Takagi M, et al. Impairedβ-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients. Clin Endocrinol (Oxf). 2000; 52: 549-555.
    • (2000) Clin Endocrinol (Oxf). , vol.52 , pp. 549-555
    • Kasayama, S.1    Otsuki, M.2    Takagi, M.3
  • 47
    • 78049235069 scopus 로고    scopus 로고
    • Cardiac effects of 3 months treatment of acromegaly evaluated by magnetic resonance imaging and B-type natriuretic peptides
    • Andreassen M, Faber J, Kjaer A, Petersen CL, Kristensen LO. Cardiac effects of 3 months treatment of acromegaly evaluated by magnetic resonance imaging and B-type natriuretic peptides. Pituitary. 2010; 13: 329-336.
    • (2010) Pituitary. , vol.13 , pp. 329-336
    • Andreassen, M.1    Faber, J.2    Kjaer, A.3    Petersen, C.L.4    Kristensen, L.O.5
  • 48
    • 77951836023 scopus 로고    scopus 로고
    • Effects of somatostatin analogues on acromegalic cardiomyopathy: Results from a prospective study using cardiac magnetic resonance
    • Bogazzi F, Lombardi M, Strata E, et al. Effects of somatostatin analogues on acromegalic cardiomyopathy: results from a prospective study using cardiac magnetic resonance. J Endocrinol Invest. 2010; 33: 103-108.
    • (2010) J Endocrinol Invest. , vol.33 , pp. 103-108
    • Bogazzi, F.1    Lombardi, M.2    Strata, E.3
  • 49
    • 84858154280 scopus 로고    scopus 로고
    • Improvement of cardiac parameters in patients with acromegaly treated with medical therapies
    • Colao A. Improvement of cardiac parameters in patients with acromegaly treated with medical therapies. Pituitary. 2012; 15: 50-58.
    • (2012) Pituitary. , vol.15 , pp. 50-58
    • Colao, A.1
  • 50
    • 0035040518 scopus 로고    scopus 로고
    • Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor i levels on cardiac performance
    • Colao A, Cuocolo A, Marzullo P, et al. Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance. J Clin Endocrinol Metab. 2001; 86: 1551-1557.
    • (2001) J Clin Endocrinol Metab. , vol.86 , pp. 1551-1557
    • Colao, A.1    Cuocolo, A.2    Marzullo, P.3
  • 51
    • 80054802844 scopus 로고    scopus 로고
    • Determinants of cardiac disease in newly diagnosed patients with acromegaly: Results of a 10 year survey study
    • Colao A, Pivonello R, Grasso LF, et al. Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study. Eur J Endocrinol. 2011; 165: 713-721.
    • (2011) Eur J Endocrinol. , vol.165 , pp. 713-721
    • Colao, A.1    Pivonello, R.2    Grasso, L.F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.